Example: Heart Attack

Search clinical trials for: Thioridazine

Total 11 results

    • NCT01765803
      Terminated
      Feasibility of Thioridazine as a Mobilizing Agent for CD34+ Hematopoietic Progenitor Cells
      Conditions: Healthy Subjects
    • NCT02096289
      Completed
      Safety Study of Thioridazine in Combination With Cytarabine to Treat Relapsed or Refractory Acute Myeloid Leukemia
      Conditions: Acute Myeloid Leukemia
    • NCT00538122
      Completed
      Changes in Heart Rhythms Associated With Antipsychotic Drug Treatment
      Conditions: Schizophrenia; Schizoaffective Disorder; Bipolar Disorder
    • NCT02435095
      Terminated
      Antipsychotic Induced Structural and Functional Brain Changes
      Conditions: Schizophrenia
    • NCT02582736
      Completed
      Antipsychotics and Risk of Hyperglycemic Emergencies
      Conditions: Psychotic Disorders; Schizophrenia; Schizoaffective Disorder; Bipolar Disorder; Diabetes Mellitus, Type 2
    • NCT02600741
      Completed
      Family Intervention in Recent Onset Schizophrenia Treatment (FIRST)
      Conditions: Schizophrenia
    • NCT02374567
      Terminated
      Pharmacovigilance in Gerontopsychiatric Patients
      Conditions: Dementia; Depression; Schizophrenia; Psychosomatic Disorders; Anxiety Disorders
    • NCT02307396
      Completed
      Evaluation of the Necessity of Long-term Pharmacological Treatment With Antipsychotics in Schizophrenic Patients
      Conditions: Schizophrenia; Schizophrenia and Disorders With Psychotic Features; Schizoaffective Disorders
    • NCT01231074
      Completed
      Reducing Antipsychotic-Induced Weight Gain in Children With Metformin
      Conditions: Obesity; Weight Gain; Psychotropic Induced Weight Gain
    • NCT04002700
      Completed
      A Study to Assess Stroke Risk Among Users of Typical Versus Atypical Antipsychotics Stratified by Broad Age Group
      Conditions: Stroke
    • NCT02191358
      Completed
      YouScript IMPACT Registry
      Conditions: Adverse Drug Events; Adverse Drug Reactions; Drug Interaction Potentiation; Drug Metabolism, Poor, CYP2D6-RELATED; Drug Metabolism, Poor, CYP2C19-RELATED; Cytochrome P450 Enzyme Deficiency; Cytochrome P450 CYP2D6 Enzyme Deficiency; Cytochrome P450 CYP2C9 Enzyme Deficiency; Cytochrome P450 CYP2C19 Enzyme Deficiency; Cytochrome P450 CYP3A Enzyme Deficiency; Poor Metabolizer Due to Cytochrome P450 CYP2C9 Variant; Poor Metabolizer Due to Cytochrome P450 CYP2C19 Variant; Poor Metabolizer Due to Cytochrome P450 CYP2D6 Variant
      Medical Conditions
      Sponsors and Collaborators
      Drug Interventions
      Conditions
      Rare Diseases
      Drug Interventions
      Dietary Supplements
      Sponsor/Collaborators
      Locations